172 material Form 8-K filings that 152 companies we cover made with the SEC in September 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Quanex reported fiscal third-quarter 2024 results for the three months ended July 31, 2024, with net sales down 6.4% from a year earlier and diluted EPS down to $0.77 from $0.96. The company said prior 2024 guidance no longer applies after the Tyman acquisition closed August 1, 2024, and issued new full-year estimates that include Tyman's contribution.
Net sales were $280.3 million vs. $299.6 million a year earlier; net income was $25.4 million vs. $31.7 million.
Adjusted diluted EPS was $0.73 vs. $0.97; Adjusted EBITDA was $42.0 million vs. $48.5 million.
New fiscal 2024 estimates: net sales of $1.275 billion to $1.285 billion and Adjusted EBITDA of $171 million to $176 million.
Management cited softer demand and lower operating leverage; a conference call is scheduled for September 6, 2024 at 11:00 a.m. ET.
UiPath reported fiscal second-quarter 2025 revenue of $316 million, up 10% year-over-year, and annual recurring revenue (ARR) of $1.551 billion, up 19%. The company still posted a GAAP operating loss of $103 million and said it raised its full-year profitability guidance, now calling for non-GAAP operating income of about $170 million. The board also authorized an additional $500 million in share repurchases and named CFO Ashim Gupta chief operating officer while he keeps the CFO role.
Q2 fiscal 2025 revenue of $316 million, up 10% year-over-year; ARR of $1.551 billion, up 19%.
GAAP operating loss of $103 million, versus $78 million a year earlier; net loss of $86 million.
Full-year fiscal 2025 guidance: revenue of $1.420 billion to $1.425 billion and non-GAAP operating income of about $170 million.
Board added $500 million to the buyback program, bringing total repurchase capacity to up to $554 million; Gupta named COO effective September 5, 2024.
Guidewire reported unaudited results for the fourth quarter and fiscal year ended July 31, 2024. Fiscal 2024 total revenue rose 8% to $980.5 million, and the GAAP net loss narrowed to $6.1 million from $111.9 million, while fourth-quarter GAAP net income was $16.8 million, up from $12.2 million, though non-GAAP net income for the quarter fell to $54.0 million from $62.8 million.
Fiscal 2024 total revenue was $980.5 million, up 8%; GAAP net loss was $6.1 million, compared with $111.9 million in fiscal 2023.
Fourth-quarter revenue was $291.5 million, up 8%; GAAP net income was $16.8 million, or $0.20 per diluted share, compared with $12.2 million, or $0.15.
Fourth-quarter non-GAAP net income was $54.0 million, compared with $62.8 million a year earlier.
Guidance for fiscal 2025 calls for total revenue of $1,135 million to $1,149 million and ARR of $995 million to $1,005 million.
Argan reported fiscal second-quarter results for the three months ended July 31, 2024, with revenue up 60.6% to $227.0 million and net income of $18.2 million, or $1.31 per diluted share, versus $0.94 a year earlier. Gross margin fell to 13.7% from 16.8%, and backlog reached $1.0 billion at quarter end, which the company says reflects an increase of approximately $210 million from the prior quarter.
Consolidated revenues were $227.0 million, up $85.7 million from $141.3 million a year earlier.
Net income was $18.2 million, or $1.31 per diluted share, compared with $12.8 million, or $0.94 per diluted share.
Gross margin was 13.7%, down from 16.8%, reflecting the changing mix of projects and contract types.
Project backlog was $1.0 billion at July 31, 2024, and cash, cash equivalents and investments totaled $484.7 million.
Docusign reported fiscal second-quarter results for the period ended July 31, 2024, with total revenue up 7% year-over-year to $736.0 million and non-GAAP diluted EPS of $0.97, up from $0.72. GAAP diluted EPS of $4.26 was driven mainly by an income tax benefit of $816.3 million, and the company issued revenue guidance for the October quarter and fiscal 2025.
Total revenue was $736.0 million, up 7% year-over-year; subscription revenue was $717.4 million, and billings were $724.5 million, up 2%.
GAAP diluted EPS was $4.26 versus $0.04 a year earlier; non-GAAP diluted EPS was $0.97 versus $0.72.
Guidance: revenue of $743 million to $747 million for the quarter ending October 31, 2024, and $2.94 billion to $2.95 billion for the fiscal year ending January 31, 2025.
G-III reported second-quarter fiscal 2025 results for the quarter ended July 31, 2024. Net sales fell 2% from a year earlier, while GAAP net income per diluted share rose to $0.53 from $0.35, and the company raised its fiscal 2025 earnings per share outlook to $3.94 to $4.04 while reaffirming its net sales forecast of $3.20 billion. The company also announced a license agreement for the Converse brand, with products expected to launch in Fall 2025.
Net sales fell 2% to $644.8 million from $659.8 million in the prior-year second quarter.
GAAP diluted EPS was $0.53 versus $0.35; non-GAAP diluted EPS was $0.52 versus $0.40.
Fiscal 2025 GAAP diluted EPS outlook raised to $3.94 to $4.04 from $3.58 to $3.68; net sales outlook unchanged at $3.20 billion.
Repaid $400 million senior secured notes due August 2025 and repurchased 1.2 million shares for $31.6 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.